Literature DB >> 9619787

A pragmatic test of a simple calorimetric method for determining the fragility of some amorphous pharmaceutical materials.

B C Hancock1, C R Dalton, M J Pikal, S L Shamblin.   

Abstract

PURPOSE: To evaluate a simple calorimetric method for estimating the fragility of amorphous pharmaceutical materials from the width of the glass transition region.
METHODS: The glass transition temperature regions of eleven amorphous pharmaceutical materials were characterized at six different heating and cooling rates by differential scanning calorimetry (DSC).
RESULTS: Activation energies for structural relaxation (which are directly related to glass fragility) were estimated from the scan rate dependence of the glass transition temperature, and correlations between the glass transition widths and the activation energies were examined. The expected correlations were observed, and the exact nature of the relationship varied according to the type of material under consideration.
CONCLUSIONS: The proposed method of determining the fragility of amorphous materials from the results of simple DSC experiments has some utility, although "calibration" of the method for each type of materials is necessary. Further work is required to establish the nature of the relationships for a broad range of amorphous pharmaceutical materials.

Mesh:

Substances:

Year:  1998        PMID: 9619787     DOI: 10.1023/a:1011931305755

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  7 in total

1.  Packing structures and transitions in liquids and solids.

Authors:  F H Stillinger; T A Weber
Journal:  Science       Date:  1984-09-07       Impact factor: 47.728

2.  Properties of citric acid at the glass transition.

Authors:  Q Lu; G Zografi
Journal:  J Pharm Sci       Date:  1997-12       Impact factor: 3.534

Review 3.  How does residual water affect the solid-state degradation of drugs in the amorphous state?

Authors:  E Y Shalaev; G Zografi
Journal:  J Pharm Sci       Date:  1996-11       Impact factor: 3.534

Review 4.  Characteristics and significance of the amorphous state in pharmaceutical systems.

Authors:  B C Hancock; G Zografi
Journal:  J Pharm Sci       Date:  1997-01       Impact factor: 3.534

5.  Crystallization of indomethacin from the amorphous state below and above its glass transition temperature.

Authors:  M Yoshioka; B C Hancock; G Zografi
Journal:  J Pharm Sci       Date:  1994-12       Impact factor: 3.534

6.  Measurement of glass transition temperatures of freeze-concentrated solutes by differential scanning calorimetry.

Authors:  L M Her; S L Nail
Journal:  Pharm Res       Date:  1994-01       Impact factor: 4.200

7.  Molecular mobility of amorphous pharmaceutical solids below their glass transition temperatures.

Authors:  B C Hancock; S L Shamblin; G Zografi
Journal:  Pharm Res       Date:  1995-06       Impact factor: 4.200

  7 in total
  10 in total

1.  Effect of moisture on the stability of a lyophilized humanized monoclonal antibody formulation.

Authors:  E D Breen; J G Curley; D E Overcashier; C C Hsu; S J Shire
Journal:  Pharm Res       Date:  2001-09       Impact factor: 4.200

2.  Time-dependence of molecular mobility during structural relaxation and its impact on organic amorphous solids: an investigation based on a calorimetric approach.

Authors:  Chen Mao; Sai Prasanth Chamarthy; Rodolfo Pinal
Journal:  Pharm Res       Date:  2006-08       Impact factor: 4.200

3.  Rapid assessment of the structural relaxation behavior of amorphous pharmaceutical solids: effect of residual water on molecular mobility.

Authors:  Danforth P Miller; David Lechuga-Ballesteros
Journal:  Pharm Res       Date:  2006-09-06       Impact factor: 4.200

4.  Comparative relaxation dynamics of glucose and maltitol.

Authors:  Sergey Vyazovkin; Ion Dranca
Journal:  Pharm Res       Date:  2006-08-09       Impact factor: 4.200

5.  Cryoprotection with L- and meso-trehalose: stereochemical implications.

Authors:  Seung-Kee Seo; Michael L McClintock; Alexander Wei
Journal:  Chembiochem       Date:  2006-12       Impact factor: 3.164

6.  Physical properties of solid molecular dispersions of indomethacin with poly(vinylpyrrolidone) and poly(vinylpyrrolidone-co-vinyl-acetate) in relation to indomethacin crystallization.

Authors:  T Matsumoto; G Zografi
Journal:  Pharm Res       Date:  1999-11       Impact factor: 4.200

7.  Identification of phase separation in solid dispersions of itraconazole and Eudragit E100 using microthermal analysis.

Authors:  Karel Six; John Murphy; Ilse Weuts; Duncan Q M Craig; Geert Verreck; Jef Peeters; Marcus Brewster; Guy Van den Mooter
Journal:  Pharm Res       Date:  2003-01       Impact factor: 4.200

8.  Effects of cooling rate on structural relaxation in amorphous drugs: elastically collective nonlinear langevin equation theory and machine learning study.

Authors:  Anh D Phan; Katsunori Wakabayashi; Marian Paluch; Vu D Lam
Journal:  RSC Adv       Date:  2019-12-04       Impact factor: 4.036

9.  Implications of global and local mobility in amorphous sucrose and trehalose as determined by differential scanning calorimetry.

Authors:  Ion Dranca; Sisir Bhattacharya; Sergey Vyazovkin; Raj Suryanarayanan
Journal:  Pharm Res       Date:  2009-01-09       Impact factor: 4.200

Review 10.  Thermal Stability of Amorphous Solid Dispersions.

Authors:  Dijana Jelić
Journal:  Molecules       Date:  2021-01-05       Impact factor: 4.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.